Science

Sakditad Saowapa: Excited to share our abstract on Proton pump inhibitors in HCC published in JCO

Sakditad Saowapa/X

Jun 5, 2025, 10:57

Sakditad Saowapa: Excited to share our abstract on Proton pump inhibitors in HCC published in JCO

Sakditad Saowapa, Oncologist at UI Holden Comprehensive Cancer Center, shared a post on X:

“Excited to share our abstract published in JCO!

PPIs in HCC = higher risks even after PSM.

Mortality: HR 1.18
DVT: HR 1.73 | PE: HR 1.96
GIB: HR 4.43 | HE: HR 3.26
SBP: HR 3.33 | Acute liver failure: HR 3.20
Global dataset | 57k+ pts

Honored to be part of this amazing team!”

Proton pump inhibitors and clinical outcomes in hepatocellular carcinoma patients: A propensity score–matched analysis from a global federated dataset.

Authors: Natchaya Polpichai, Sakditad Saowapa, Shu-Yen Chan, Manasawee Tanariyakul, Chanakarn Kanitthamniyom, Andrea Ortiz Maldonado, Chanokporn Puchongmart, Nattanicha Chaisrimaneepan, Miriam Paz Sierra, Phuuwadith Wattanachayakul, Rawipan Uaratanawong, Pharit Siladech, and Lukman Aderoju Tijani.

You can read the full article on Journal of Clinical Oncology.

Sakditad Saowapa: Excited to share our abstract on Proton pump inhibitors in HCC published in JCO

More posts featuring Sakditad Saowapa.

Andrea Ortiz Maldonado cancer Chanakarn Kanitthamniyom Chanokporn Puchongmart fight against cancer Global fight against cancer HCC hepatocellular carcinoma JCO Lukman Aderoju Tijani Manasawee Tanariyakul Miriam Paz Sierra Natchaya Polpichai Nattanicha Chaisrimaneepan OncoDaily Oncology Pharit Siladech Phuuwadith Wattanachayakul PPIs Proton pump inhibitors Rawipan Uaratanawong Sakditad Saowapa Shu-Yen Chan UI Holden Comprehensive Cancer Center

Hubert Caron Retires from Roche-Genentech

Ramy Sedhom: Palliative Care Isn’t Just about When. It’s about Who, What, and How

Miriam Mutebi: One Small Grant, One Big Difference

Jasmine Kamboj: How We Bring Ourselves to the Table as Leaders

Zongertinib Gets FDA Green Light for HER2+ NSCLC